Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.59
-0.04 (-1.52%)
At close: Aug 19, 2025, 12:02 PM

Orchestra BioMed Revenue

Orchestra BioMed reported an annual revenue of $2.64M, reflecting a -4.42% growth. For the quarter ending June 30, 2025, Orchestra BioMed generated $836K in revenue.
Revenue (ttm)
2.64M
Revenue Growth
-4.42%
Price / Sales Ratio
55.83
Revenue / Employee
37.69K
Employees
70
Market Cap
139.74M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 2.64M -4.42%
Dec 31, 2023 2.76M -21.88%
Dec 31, 2022 3.53M +-551.79%
Dec 31, 2021 -782K -113.71%
Dec 31, 2020 5.7M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.